ISO 14971 and the Risk Management of Medical Devices
ISO 14971 is the global standard for managing risks in medical devices, guiding manufacturers through identifying, evaluating, and mitigating risks
CE Mark & UKCA Mark Technical Files
We provide support in updating your Technical including modifications or design updates to your device, revising and enhancing your risk management file, and ensuring your files are compliant.
Medical Device Technical Files & IVD Technical Files - CE marking
Medical Devices placed on the European Union (EU) market must comply with the Medical Device Regulations (MDR) EU 2017/745. Similarly, In Vitro Diagnostic Devices (IVD) must adhere to the In Vitro Diagnostic Regulations (IVDR) EU 2017/746. Compliance mandates Technical Files to align with Annex I, Annex II, and Annex III of these regulations.
Each medical device category necessitates its dedicated Technical File. Crafting these files can be perplexing, potentially leading to Notified Bodies identifying non-conformities if the correct data and format are not precise.
Ensuring precision in your Technical Files is vital. To achieve this, entrust the task to experts in regulatory affairs. Their expertise guarantees compliance, minimizing costly errors. Patient Guards consultancy services, staffed by skilled and qualified professionals, offer to create Technical Files for new devices or convert files from the older medical device directives.
Get support from our professional team
Additionally, we provide support in updating your Technical Files as needed. This includes modifications or design updates to your device, revising and enhancing your risk management file, and ensuring your files comply with post-market surveillance obligations and clinical safety requirements. Crafting Technical Files for medical devices is a meticulous process, crucial for compliance with EU regulations. The Technical File serves as comprehensive documentation demonstrating conformity with the essential requirements outlined in Annex II of the Medical Device Regulations (MDR) EU 2017/745 or the In Vitro Diagnostic Regulations (IVDR) EU 2017/746, depending on the device category.
Navigating the complexity of Regulations
These regulations mandate adherence to Annex I, Annex II, and Annex III, necessitating precise alignment within the Technical File. Failure to meet these requirements can result in non-conformities flagged by Notified Bodies during audits or assessments.
Precision in Technical Files is paramount, demanding the expertise of regulatory affairs specialists. Entrusting this task to skilled professionals mitigates the risk of costly errors and ensures compliance with regulatory standards. Patient Guards consultancy services boast a team of qualified professionals adept at creating Technical Files for both new devices and conversions from previous medical device directives.
Furthermore, our support extends to updating Technical Files as necessary, encompassing modifications or design enhancements to devices, revising risk management documentation, and ensuring alignment with post-market surveillance and clinical safety obligations.
Ensure your Medical Device and IVD Compliance
By leveraging the expertise of regulatory affairs professionals and adhering to regulatory requirements outlined in Annex II of the MDR or IVDR, medical device manufacturers can navigate the complex landscape of compliance with confidence, safeguarding both patient safety and market access.
The process of creating and maintaining Technical Files involves several key steps. Initially, manufacturers must gather and organize all relevant documentation, including design specifications, manufacturing processes, risk assessments, clinical data, and labelling information. This information must be meticulously compiled and formatted according to the specific requirements outlined in Annex II of the applicable regulations.
Once the documentation is assembled, manufacturers must ensure that it accurately reflects the design, manufacture, and intended use of the medical device. This may involve conducting additional testing or studies to gather supporting data, as well as consulting with experts in relevant fields to ensure that all aspects of the device’s performance and safety are adequately addressed.
Once the Technical File is complete, it must be submitted to Notified Bodies for review and the appropriate regulatory authorities, if necessary, unless it is a Class I medical device. Class I medical devices can be placed on the market without Notified Bodies issuing a CE mark certificate. However, Class I medical devices must still have technical files following the process mentioned above. This
In addition to the initial creation of Technical Files, manufacturers must also ensure that they are kept up to date with any changes or updates to the device or its regulatory requirements. This may involve periodically reviewing and revising the Technical File to reflect changes in the device design, manufacturing process, or regulatory standards.
Overall, the creation and maintenance of Technical Files is a complex and critical aspect of regulatory compliance for medical device manufacturers. By following best practices and leveraging the expertise of regulatory affairs professionals, manufacturers can ensure that their Technical Files are accurate, comprehensive, and up to date, thereby facilitating the approval and commercialization of their products in the EU market.
Medical Device Technical Files & IVD Technical Files - UKCA marking
In January 2021, the United Kingdom (UK) officially severed ties with the European Union (EU), marking a significant shift in regulatory frameworks for medical devices. Emerging as a third country, the UK introduced its own set of regulations to govern the entry and circulation of medical devices within its borders. This seismic change brought about a profound impact on manufacturers, regulatory bodies, and the broader healthcare landscape. It necessitated a revaluation of compliance strategies, conformity assessment procedures, and market access requirements.
Despite the divergence from the EU regulatory regime, medical devices bearing the CE mark, signifying conformity with EU regulations, can still be legally sold in the UK market during a transition period. This transitional arrangement provided a degree of continuity and facilitated the smooth flow of medical devices into the UK market. However, recognizing the need for a regulatory framework tailored to its own jurisdiction, the UK swiftly introduced the UKCA (UK Conformity Assessed) mark.
The UKCA mark serves as a symbol of compliance with UK regulations, indicating that a medical device meets the requisite safety, quality, and performance standards mandated by the UK authorities. For manufacturers seeking to market their medical devices or in vitro diagnostic devices (IVDs) in the UK, obtaining UKCA certification from a UK authorised Notified Body is now a prerequisite. This requirement underscores the UK’s commitment to upholding robust regulatory standards and ensuring patient safety within its borders.
If you need support with Medical Device or IVD UKCA marking we are here to help
Navigating the evolving regulatory landscape in the UK poses challenges, particularly for manufacturers of Class I medical devices and Class A IVDs. Achieving compliance entails not only obtaining UKCA certification but also adhering to stringent regulatory requirements, including product registration with the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulatory authority for medical devices. For manufacturers based outside the UK, appointing a Responsible Person is essential for facilitating regulatory compliance and market entry.
As the UK government continues to refine its regulatory framework post-Brexit, manufacturers must remain vigilant and adaptable. Public consultations and stakeholder engagements play a crucial role in shaping future regulations, with anticipated changes set to come into effect by 2025. These regulatory developments may encompass a wide range of areas, including conformity assessment procedures, labeling requirements, post-market surveillance obligations, and clinical data requirements.
Why Choose Patient Guard?
Patient Guard is at the forefront of assisting manufacturers in navigating the complexities of UK regulatory compliance. Our multidisciplinary team of regulatory experts offers a comprehensive suite of services tailored to meet the diverse needs of medical device manufacturers. From crafting new Technical Files for companies entering the UK market to updating existing documentation to align with UKCA marking requirements, we provide strategic guidance and practical solutions to ensure compliance and market success.
Furthermore, as regulatory updates and changes are implemented, Patient Guard remains dedicated to keeping our clients informed and prepared. Our proactive approach to regulatory compliance ensures that manufacturers stay ahead of the curve, mitigating risks and seizing opportunities in the dynamic landscape of UK medical device regulation. With Patient Guard as your trusted partner, you can navigate the complexities of the UK market with confidence, knowing that your regulatory compliance needs are in expert hands.
Patient Guard have been a great support service to Cormed, providing help and advice promptly whenever requested. They have become a virtual department within Cormed enabling us to keep up to date and comply with the regulatory requirements whilst ensuring our QMS works for us at the same time.
Tracey Slater, Cormed
Find out more about medical device compliance and regulations
EUDAMED
The EU Commission has recently announced that the transition period for completing and implementing EUDAMED has been extended again. The
In Vitro Diagnostic Regulations (IVDR) – EU 2017/746
In the ever-evolving landscape of healthcare, in vitro diagnostic (IVD) devices are indispensable tools, providing invaluable insights into patients’ health
Navigating the Future: The Growing Medical Device Industry and the Role of Regulation
The medical device industry has witnessed remarkable growth in recent years, and its expansion shows no signs of slowing down.
